Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Medpace Holdings, Inc. (MEDP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/27/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/24/2023 8-K Quarterly results
06/07/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/25/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/25/2023 144 Form 144 - Report of proposed sale of securities:
04/24/2023 8-K Quarterly results
04/05/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/05/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 ARS Form ARS - Annual Report to Security Holders:
03/31/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "BACKGROUND"
02/14/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
02/13/2023 8-K Quarterly results
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.7% stake in Medpace Holdings Inc.
02/08/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2023 SC 13G/A BlackRock Inc. reports a 10.2% stake in Medpace Holdings Inc
01/20/2023 SC 13G/A BlackRock Inc. reports a 10.2% stake in Medpace Holdings Inc
01/18/2023 8-K Quarterly results
01/03/2023 8-K Quarterly results
10/25/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/24/2022 8-K Quarterly results
09/21/2022 SC 13D/A Troendle August J. reports a 23.9% stake in Medpace Holdings, Inc.
09/13/2022 SC 13D/A Troendle August J. reports a 22.5% stake in Medpace Holdings, Inc.
07/26/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/25/2022 8-K Quarterly results
07/06/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/10/2022 8-K Quarterly results
05/26/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
04/26/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/25/2022 8-K Quarterly results
Docs: "Medpace Holdings, Inc. Reports First Quarter 2022 Results • Revenue of $330.9 million in the first quarter of 2022 increased 27.3% from revenue of $260.0 million for the comparable prior-year period, representing a backlog conversion rate of 16.6%. • Net new business awards were $423.0 million in the first quarter of 2022, representing an increase of 18.8% from net new business awards of $356.2 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.28x. • First quarter of 2022 GAAP net income was $61.3 million, or $1.69 per diluted share, versus GAAP net income of $43.3 million, or $1.14 per diluted share, for the comparable prior-year period. Net income margin was 18.5% and 16.7% for the first quarter of 2022 and 2021, respective..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy